Advertisement
In the treatment of COVID-19 patients

Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients

0
FDA says chloroquine or hydroxychloroquine could reduce the antiviral effectiveness of remdesivir
The cumulative incidence of COVID-19 is 403.6 cases per 100

CDC: Cumulative Incidence of COVID-19 403.6 Per 100,000 in U.S.

0
Hospitalization and mortality six times, 12 times higher for patients reporting an underlying condition
For patients with thoracic cancer

COVID-19 Death Rate High for Patients With Thoracic Cancer

0
Of those eligible for intensive care unit admission, only 10 percent admitted to ICU
With most state reopenings well underway

COVID-19 Cases Rising in Many States as Reopening Continues

0
25,000 complaints filed against businesses in Manhattan and elsewhere for violating reopening plan
Black Americans are much more likely than other Americans to say a relative or close friend has died of COVID-19

Black Americans Much More Likely to Have Lost Loved Ones to COVID-19

0
11 percent of black adults say someone close to them has died; rates are 5 percent among Americans overall
Nearly 43

Nearly 43,000 Pounds of Ground Beef Products Recalled

0
Products sold across the United States under the labels Marketside Butcher and Thomas Farms
The American Red Cross will test all blood

Blood Donors Will Get Results of Coronavirus Antibody Test, Red Cross Says

0
Positive test result does not confirm immunity to the virus, and test is not meant to diagnose illness
The U.S. Food and Drug Administration has withdrawn its emergency authorization for the use of chloroquine phosphate and hydroxychloroquine sulfate in the fight against COVID-19.

FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

0
Agency now says the drugs should not be used outside of clinical trials
About 6.1 percent of parents are hesitant about routine childhood vaccines

More Than One in Four Parents Hesitant About Flu Vaccine

0
Seventy and 26 percent strongly agree that routine and flu vaccines are effective, respectively
Nonpharmaceutical interventions have been beneficial for slowing COVID-19 growth on a global level and within Europe

Nonpharmaceutical Interventions Slow COVID-19 Growth

0
Interventions achieved beneficial outcomes in global study in six countries and in Europe-wide study